Susceptibility of spontaneously hypertensive rats to the diabetogenic effects of streptozotocin

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 11, 1996, Pages 1215-1221

  Jian, Kong ^a   Fok, Esther ^a   Cam, Margaret C ^a   Sambandam, Nandakumar ^a   Yao, Jun ^a   Rodrigues, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Oral glucose tolerance test; Pancreatic insulin; Plasma triglycerides; Spontaneously hypertensive rats; Streptozotocin

Indexed keywords

INSULIN; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 0030512665     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-137     Document Type: Article

References (44)

1. Bader, S., Scholz, R., Kellerer, M., Tippmer, S., Rett, K., Mathaei, S., Freund, P., and Haring, H.U. 1992. Normal insulin receptor tyrosine kinase activity and glucose transporter (GLUT 4) levels in skeletal muscle of hyperinsulinemic hypertensive rats. Diabetologia, 35: 712-718.
2. Bonnevie-Nielsen, V., Steffes, M.W., and Lernmark, A. 1981. A major loss in islet mass and β-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes, 30: 424-429.
3. Buchanan, T.A., Sipos, G.F., Madrilejo, N., Liu, C., and Campese, V.M. 1992. Hypertension without peripheral insulin resistance in spontaneously hypertensive rats. Am. J. Physiol. 262: 14-19.
4. Bunag, R.D. 1973. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J. Appl. Physiol. 34: 279-282.
5. Burcelin, R., Eddouks, M., Maury, J., Kande, J., Assan, R., and Gerad, J. 1995. Excessive glucose production, rather than insulin resistance, accounts for hyperglycemia in recent-onset streptozotocin-diabetic rats. Diabetologia, 38: 283-290.
6. Cam, M.C., and McNeill, J.H. 1996. A sensitive radioimmunoassay optimized for reproducible measurement of rat plasma insulin. J. Pharmacol. Toxicol. Methods, 35: 111-119.
7. Christe, M.E., and Rodgers, R.L. 1994. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J. Mol. Cell. Cardiol. 26: 1371-1375.
8. Christe, M.E., and Rodgers, R.L. 1995. Cardiac glucose and fatty acid oxidation in the streptozotocin-induced diabetic spontaneously hypertensive rat. Hypertension (Dallas), 25: 235-241.
9. Chukwuma, C.J. 1992. Comments on the clinical impact of hypertension in type I diabetes. J. Diab. Comp. 6: 197-202.
10. Cooper, M.E., Allen, T.J., Macmillar, P., Bach, L., Jerums, G., and Doyle, A.E. 1988. Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat. Am. J. Hypertens. 1: 5-10.
11. Dai, S., Lee, S., Battell, M., and McNeill, J.H. 1994. Cardiovascular and metabolic changes in spontaneously hypertensive rats following streptozotocin administration. Can. J. Cardiol. 10: 562-570.
12. Davidoff, A.J., Pinault, F.M., and Rodgers, R.L. 1990. Ventricular relaxation of diabetic spontaneously hypertensive rat. Hypertension (Dallas), 15: 643-651.
13. Factor, S.M., Minase, T., and Sonnenblick, E.H. 1980. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am. Heart J. 99: 446-458.
14. Fein, F.S., Capasso, J.M., Aronson, R.S., Cho, S., Nordin, C., Miller-Green, B., Sonnenblick, E.H., and Factor, S.M. 1984. Combined renovascular hypertension and diabetes in rats: a new preparation of congestive cardiomyopathy. Circulation, 70: 318-330.
15. Galan, X., Llobera, M., and Ramirez, I. 1994. Lipoprotein lipase and hepatic lipase in Wistar and Sprague-Dawley rat tissues. Differences in the effects of gender and fasting. Lipids, 29: 333-336.
16. Gibbons, G.F. 1990. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem. J. 268: 1-13.
17. Hammes, H.P., Brownlee, M., Edelstein, D., Saleck, M., Martin, S., and Federlin, K. 1994. Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia, 37: 32-35.
18. Hulman, S., Falkner, B., and Freyvogel, N. 1993. Insulin resistance in the conscious spontaneously hypertensive rat: euglycemic hyperinsulinemic clamp study. Metabolism, 42: 14-18.
19. Iritani, N., Fukuda, E., Nara, Y., and Yamori, Y. 1971. Lipid metabolism in spontaneously hypertensive rats (SHR). Atherosclerosis, 28: 217-222.
20. Iwase, M., Kodama, T., Himeno, H., Yoshinari, M., Tsutsu, N., Sadoshima, S., and Fujishima, M. 1994. Effect of aging on glucose tolerance in spontaneously hypertensive rats. Clin. Exp. Hypertens. 16: 67-76.
21. Jablonskis, L.T., and Howe, P.R. 1994. Elevated plasma adrenaline in spontaneously hypertensive rats. Blood Pressure, 3: 106-111.
22. Johnson, M.L., Ely, D.I., and Turner, M.E. 1992. Genetic divergence between the Wistar-Kyoto rat and the spontaneously hypertensive rat. Hypertension (Dallas), 19: 425-427.
23. Johnston, C.I., Cooper, M.E., and Nicholls, G.M. 1992. Meeting report of the International Society of Hypertension Conference on Hypertension and Diabetes. J. Hypertens. 10: 393-397.
24. Knowler, W.C., Bennett, P.H., and Ballantine, E.J. 1980. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. New Engl. J. Med. 302: 645-650.
25. Mamo, J.C.L., Hirano, T., Sainsbury, A., Fitzgerald, A.K., and Redgrave, T.G. 1992. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats. Biochim. Biophys. Acta, 1128: 132-138.
26. Masiello, P., De Paoli, A.A., and Bergamini, E. 1979. Influence of age on the sensitivity of the rat to streptozotocin. Horm. Res. 11: 262-274.
27. Mauer, S.M., Steffes M.W., Azar, S., Sandberg, S.K., and Brown, D.M. 1978. The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes, 27: 738-744.
28. McCulloch, D.K., Koerker, D.J., Kahn, S.E., Bonner-Weir, S., and Palmer, J.P. 1991. Correlations of in vivo β-cell function tests with β-cell mass and pancreatic insulin content in streptozotocin-administered baboons. Diabetes, 40: 673-679.
29. Parving, P.P., Andersen, A.R., Smidt, U.M., and Svendsen, P.A. 1983. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephrophathy. Lancet, 1: 1175-1179.
30. Ramirez, I., Kryski, A., Jr., Ben-Zeev, O., Schotz, M.C., and Severson, D.L. 1985. Characterization of triacylglycerol hydrolase activities in isolated myocardial cells from rat heart. Biochem. J. 23: 229-236.
31. Rao, R.H. 1993. Insulin resistance in spontaneously hypertensive rat. Difference in interpretation based on insulin infusion rate or on plasma insulin in glucose clamp studies. Diabetes, 42: 1364-1371.
32. Reaven, G.M., and Chang, H. 1991. Relationship between blood pressure, plasma insulin and triglyceride concentration and insulin action in spontaneously hypertensive and Wistar Kyoto rats. Am. J. Hypertens. 4: 34-38.
33. Rodrigues, B., and McNeill, J.H. 1986. Cardiac function in spontaneously hypertensive diabetic rats. Am. J. Physiol. 251: 571-580.
34. Rodrigues, B., and Severson, D.L. 1993. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats. Can. J. Physiol. Pharmacol. 71: 657-661.
35. Rodrigues, B., Braun, J.E.A., Spooner, M., and Severson, D.L. 1992. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids. Can. J. Physiol. Pharmacol. 70: 1271-1279.
36. Sambandam, N., Chen, X., Cam, M.C., and Rodrigues, B. 1996. Cardiac lipoprotein lipase in the spontaneously hypertensive rat. Cardiovasc. Res. In press.
37. Sato, T., Nara, Y., Note, S., and Yamori, Y. 1987. New establishment of hypertensive diabetic animals: neonatally streptozotocin-treated spontaneously hypertensive rats. Metabolism, 36: 731-737.
38. Singer, P., Berger, I., Moritz, V., and Baumann, R. 1980. High post heparin lipolytic activity as a possible cause of hypotriglyceridemia in spontaneously hypertensive rats. Acta Biol. Med. Ger. 39: 819-824.
39. Somani, P., Singh, H.P., Saini, R.K., and Rabinovitch, A. 1979. Streptozotocin-induced diabetes in the spontaneously hypertensive rat. Metabolism, 28: 1075-1077.
40. St. Lezin, E., Simonet, L., Pravenec, M., and Kurtz, T.W. 1992. Hypertensive strains and normotensive 'control' strains: how closely are they related? Hypertension (Dallas), 19: 419-424.
41. Tonooka, M., Kawashima, I., Sakashita, M., Yasuhara, H., and Sakamoto, K. 1985. Effects of chronic treatment of propranolol on lipid metabolism in spontaneously hypertensive rats (SHR). Jpn. J. Pharmacol. 37: 335-344.
42. Voss, C., Moritz, V., Hartmann, K., Herrmann, I., Hahn von Dorsche, H., and Zhlke, H. 1989. Streptozotocin diabetes in spontaneously hypertensive rats. Exp. Clin. Endocrinol. 93: 231-240.
43. Yamamoto, J. 1988. Blood pressure and metabolic effects of streptozotocin in Wistar-Kyoto and spontaneously hypertensive rats. Clin. Exp. Hypertens. 10: 1065-1083.
44. Yoshimoto, S., Sakamoto, K., Wakabayashi, I., and Masui, H. 1992. Effect of chromium administration on glucose tolerance in stroke-prone spontaneously hypertensive rats with streptozotocin-induced diabetes. Metabolism, 41: 636-642.